By Ethan B. Russo | 18th Octobre 2018 Neurological therapeutics have been hampered by its inability to advance beyond symptomatic treatment of neurodegenerative disorders into the realm of actual palliation, arrest or reversal of the attendant pathological processes. While cannabis-based medicines have demonstrated safety, efficacy and consistency sufficient for regulatory approval in spasticity in multiple sclerosis (MS), and in Dravet and Lennox-GastautRead more
Tag Archives: PARKINSONS
SOURCE: THE ICCI With specific reference to Parkinson’s Disease (please read to the end of this blog for the link to the full Review). About: An undeniable global interest in the study of cannabis treatments inspired the creation of the International Cannabis and Cannabinoid Institute (ICCI), the first Center of Excellence in this field located in the heart of EuropeRead more
Cannabis Hemp Conference and Expo Published on 22 Jun 2017 Dear Dr. Ethan, Thank you for your prompt responses to our communications and for your highly valued knowledge. Kind regards, Nicholas Hill The Hemp Club SOURCE, YOUTUBE: https://www.youtube.com/watch?v=xtphZejvGhkRead more
I am helping a dear old with Parkinson’s and we started ENDOCA CBD15% 1500mg. 5mg drops 1 -3 times a day for the first week build to 2 -3 times a day and so on until we get to the perfect dose. He is on good form having started and sleeps and eats better than […]Read more
Detailed analysis of selected pathological conditions and effects of cannabis and its derivatives with weaker clinical evidence and a strong theoretical basis favoring effectiveness. With reference to Parkinson’s disease.
A short quote from the .pdf (a link to the detailed analysis is at the end of this post). ” Parkinson’s disease This disease, whose symptoms especially include a decrease in the number of dopaminergic neurons in the basal ganglia (“BG”), is, due to its high prevalence (especially among older patients) and simultaneous existence of endocannabinoid receptors in the BGRead more